The mechanisms of lncRNA GAS5 in cardiovascular cells and its potential as novel therapeutic target

J Drug Target. 2020 Dec;28(10):1012-1017. doi: 10.1080/1061186X.2020.1769108. Epub 2020 May 25.

Abstract

Long noncoding RNAs (lncRNAs) are a large class of non (protein)-coding RNAs, which are longer beyond 200 nucleotides. LncRNA GAS5 is widely considered as a tumour suppressor in cell proliferation, apoptosis, cell migration and invasion of tumour cells. Recently, a growing body of evidences indicated that GAS5 was also widely involved in the pathologic process of cardiovascular cells, including regulation of apoptosis and inflammatory injury of cardiomyocytes; proliferation, apoptosis, autophagy and angiogenesis of endothelial cells; and proliferation, migration, apoptosis and differentiation of VSMCs. In this regard, we summarised current studies of GAS5 in cardiovascular cells, which shed light on not only our understanding of the mechanisms of GAS5 in cardiovascular cells but also understanding of the potential of GAS5 as novel therapeutic target.

Keywords: GAS5; cardiovascular cells; long noncoding RNAs.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Apoptosis
  • Cell Movement
  • Cell Proliferation
  • Endothelial Cells / drug effects*
  • Humans
  • Mice
  • Myocytes, Cardiac / drug effects*
  • RNA, Long Noncoding / pharmacology*

Substances

  • GAS5 long non-coding RNA, human
  • RNA, Long Noncoding